When Azoles Cannot Be Used: The Clinical Effectiveness of Intermittent Liposomal Amphotericin Prophylaxis in Hematology Patients

BACKGROUND: Patients unable to take azoles are a neglected group lacking a standardized approach to antifungal prophylaxis. We evaluated the effectiveness and safety of intermittent liposomal amphotericin B (L-AMB) prophylaxis in a heterogenous group of hematology patients. METHODS: A retrospective...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Open Forum Infect Dis
Autors principals: Batchelor, R, Thomas, C, Gardiner, B J, Lee, S J, Fleming, S, Wei, A, Coutsouvelis, J, Ananda-Rajah, M
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2021
Matèries:
Major Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8318248/
https://ncbi.nlm.nih.gov/pubmed/34337090
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofab113
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars